Justia Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

The FTC also touted its settlement of the Amgen/Horizon matter (here and here) although, as I explained in December, the core of the consent order—reached on the eve of trial—had been proposed by Amgen all along. [read post]

Truth on the Market - http://truthonthemarket.com/

Vanda Seeks Supreme Court Review on Lower Standard for Obviousness

23 Jan 2024, 3:43 am by Dennis Crouch

Vanda Pharmaceuticals Inc., v. [read post]

Patently-O - https://patentlyo.com

Wachtell Lipton Discusses U.S. M&A Antitrust Enforcement for 2023 and the Year Ahead

21 Jan 2024, 9:01 pm by renholding

In Seven & i Holdings Co., Ltd. and 7-Eleven, Inc. [read post]

The CLS Blue Sky Blog - https://clsbluesky.law.columbia.edu/

USPTO Issues “Reasonable” Guidance on Enablement Under Amgen v. Sanofi

18 Jan 2024, 5:14 pm by bklemm@foley.com

Share on LinkedInShare on TwitterShare by EmailShare Back to top The USPTO has issued “Guidelines for Assessing Enablement in Utility Applications and Patents in View of the Supreme Court Decision in Amgen Inc. et al. v. [read post]

PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents

USPTO Guidelines: Amgen is a Nothingburger

11 Jan 2024, 12:59 pm by Dennis Crouch

Genentech, Inc., 81 F.4th 1362 (Fed. [read post]

Patently-O - https://patentlyo.com

Federal Circuit Affirms Invalidity of Genus Claims to Stevia Production Method Lacking Written Description and Narrower Claims as Combining Natural Phenomena with an Abstract Idea

4 Jan 2024, 9:42 am by Dennis Crouch

SweeGen, Inc., No. 22-1946 (Fed. [read post]

Patently-O - https://patentlyo.com

Top IP Developments of 2023

31 Dec 2023, 4:29 pm by Thomas James

Enablement Amgen v. [read post]

Cokato Copyright Attorney - https://www.thomasbjames.com

The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients

20 Dec 2023, 5:00 am by Timothy Bonis

Monoclonal Antibodies Inc., 1985) protected large genus claims. [read post]

Bill of Health - https://blog.petrieflom.law.harvard.edu/

Pharmaceutical Industry Prepares for Regulatory Shift as FTC Shifts Antitrust Tactics

11 Dec 2023, 5:05 am by Rob Robinson

Companies across the pharmaceutical landscape are adapting to this new environment, including Amgen Inc., whose $43 billion takeover of Seagen Inc. faces a rigorous FTC review. [read post]

ComplexDiscovery - https://complexdiscovery.com/

Blog Post: Patent Enablement Lessons from Amgen Inc. v. Sanofi

4 Dec 2023, 10:00 pm by Sherica Celine

Watch now » Related Content Amgen Patent Ruling's Impact Extends Beyond Life Sciences Gain insight from Law360 expert analysis on the impacts of Amgen Inc. v. [read post]

Legal Insights Blog - https://www.lexisnexis.com/community/insights/legal/

Laser Lessons: Has the Supreme Court Undermined Pioneering Laser Patents?

3 Dec 2023, 9:15 am by Roy Wepner

It seems likely that Amgen Inc. v. [read post]

IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com

Laser Lessons: Has the Supreme Court Undermined Pioneering Laser Patents?

3 Dec 2023, 9:15 am by Roy Wepner

It seems likely that Amgen Inc. v. [read post]

IPWatchdog - http://www.ipwatchdog.com/

Supreme Court on Patent Law: November 2023

29 Nov 2023, 8:41 am by Dennis Crouch

The Federal Circuit rejected this argument based on dicta in Thryv, Inc. v. [read post]